The relationship between vascular and metabolic characteristics of primary breast tumours

Semple, Scott; Gilbert, Fiona; Redpath, Thomas; Staff, Roger; Ahearn, Trevor; Welch, Andrew; Heys, Steven; Hutcheon, Andrew; Smyth, Elizabeth; Chaturvedi, Shailesh; Semple, Scott I K; Gilbert, Fiona J; Redpath, Thomas W; Staff, Roger T; Ahearn, Trevor S; Welch, Andrew E; Heys, Steven D; Hutcheon, Andrew W; Smyth, Elizabeth H
November 2004
European Radiology;Nov2004, Vol. 14 Issue 11, p2038
Academic Journal
journal article
The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[(18)F] fluoro-2-deoxy- d-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association ( P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.


Related Articles

  • A Physiological Perspective on the Use of Imaging to Assess the In Vivo Delivery of Therapeutics. Qin, Shengping; Fite, Brett; Gagnon, M.; Seo, Jai; Curry, Fitz-Roy; Thorsen, Frits; Ferrara, Katherine // Annals of Biomedical Engineering;Feb2014, Vol. 42 Issue 2, p280 

    Our goal is to provide a physiological perspective on the use of imaging to optimize and monitor the accumulation of nanotherapeutics within target tissues, with an emphasis on evaluating the pharmacokinetics of organic particles. Positron emission tomography (PET), magnetic resonance imaging...

  • Comparative evaluation of 18F-FDOPA, 13N-AMMONIA, 18F-FDG PET/CT and MRI in primary brain tumors - A pilot study. Jora, Charu; Mattakarottu, Jacob J.; Aniruddha, Pandit G.; Mudalsha, Ravina; Singh, Dhananjay K.; Pathak, Harish C.; Sharma, Nitin; Sarin, Arti; Prince, Arvind; Singh, Giriraj // Indian Journal of Nuclear Medicine;Apr-Jun2011, Vol. 26 Issue 2, p78 

    Aim: To determine the diagnostic reliability of 18F-FDOPA, 13N-Ammonia and 18F-FDG PET/CT in primary brain tumors and comparison with magnetic resonance imaging (MRI). Materials and Methods: A total of 23 patients, 8 preoperative and 15 postoperative, undergoing evaluation for primary brain...

  • PET imaging in the surgical management of pediatric brain tumors. Pirotte, Benoit; Acerbi, Francesco; Lubansu, Alphonse; Goldman, Serge; Brotchi, Jacques; Levivier, Marc // Child's Nervous System;Jul2007, Vol. 23 Issue 7, p739 

    Objective: The present article illustrates whether positron-emission tomography (PET) imaging may improve the surgical management of pediatric brain tumors (PBT) at different steps. Materials and methods: Among 400 consecutive PBT treated between 1995 and 2005 at Erasme Hospital, Brussels,...

  • Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Tessonnier, L.; Sebag, F.; Palazzo, F.; Colavolpe, C.; Micco, C.; Mancini, J.; Conte-Devolx, B.; Henry, J.; Mundler, O.; Taïeb, D. // European Journal of Nuclear Medicine & Molecular Imaging;Nov2008, Vol. 35 Issue 11, p2018 

    The widespread use of high-resolution cross-sectional imaging such as computed tomography (CT) and magnetic resonance imaging (MRI) for the investigation of the abdomen is associated with an increasing detection of incidental adrenal masses. We evaluated the ability of 18F-fluorodeoxyglucose...

  • Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Ng, Shu-Hang; Chan, Sheng-Chieh; Yen, Tzu-Chen; Chang, Joseph; Liao, Chun-Ta; Ko, Sheung-Fat; Liu, Feng-Yuan; Chin, Shu-Chyn; Fan, Kang-Hsing; Hsu, Cheng-Lung // European Journal of Nuclear Medicine & Molecular Imaging;Jan2009, Vol. 36 Issue 1, p12 

    We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC). A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan)...

  • PET-CT Evaluates Cancer In Children Better. Volkin, Laurie; Dargan, Richard S. // ASRT Scanner;Mar2008, Vol. 40 Issue 6, p5 

    The article discusses research being done on the use of positron emission tomography-computed tomography (PET-CT) to diagnose cancer in children. It references a study published in the December 2007 issue of the "Journal of Nuclear Medicine." Researchers compared the sensitivity and efficacy of...

  • PET/CT Imaging Appears To Be More Accurate Than MRI At Staging Tumors. Bauer, Jeff // RN;Mar2004, Vol. 67 Issue 3, p17 

    Examines the usability of positron emission tomography/computed tomography (PET/CT) in staging tumors by researchers from the U.S. Accuracy of the procedure; Advantage of using a combined whole-body PET/CT imaging over whole-body magnetic resonance imaging; Evaluation on the efficacy of PET/CT...

  • Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Galldiks, Norbert; Ullrich, Roland; Schroeter, Michael; Fink, Gereon; Kracht, Lutz // European Journal of Nuclear Medicine & Molecular Imaging;Jan2010, Vol. 37 Issue 1, p84 

    We investigated the relationship between three-dimensional volumetric data of the metabolically active tumour volume assessed using [11C]-methionine positron emission tomography (MET-PET) and the area of gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) enhancement assessed using magnetic...

  • SUV and segmentation: pressing challenges in tumour assessment and treatment. Lucignani, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;Apr2009, Vol. 36 Issue 4, p715 

    The article discusses the importance of various imaging techniques in detecting tumours. It says that the combination of imaging techniques including X-ray computed tomography (CT), magnetic resonance imaging and positron emission tomography (PET), have characterized the biological features of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics